Telecom Network Equipment Manufacturer Gains Deep Understanding of its Business Interruption Exposures

A global telecoms network equipment manufacturer was keen to identify its internal and external suppliers’ exposure to business interruption risks. The manufacturer needed detailed exposure data to help inform its risk management decisions and direct its thinking about insurance limits.

The business has huge annual investments in R&D to produce the Application-Specific Integrated Circuits (ASICs) and software used to run its equipment. This technology is the lifeblood of the business and the ‘brains’ behind the products.

Consequently, the business holds many patents to protect its intellectual property. It relies heavily on outsourcing, particularly for chipset production. It also buys third-party patented ASICs that work with its products.

The business has many owned production facilities plus a range of Electronics Manufacturing Services (EMS) providers. This diverse supply created the need for a detailed supply chain exposure assessment.

Supply Chain Exposure Study for NHS Supplier of Medically Critical Medicines

A supplier of medically critical medicines to the NHS, was looking to map every stage of its long and complex supply chain, right from raw materials through to its wholesalers.

A biopharma supplier undertakes a supply chain risk analysis to demonstrate its rigorous approach to client fulfilment

A supplier to major biopharmaceutical companies was identified as the sole source of certain biopharma materials. Consequently, one of these companies required evidence of the supplier’s supply chain risk analysis, as part of a due diligence exercise.

Furthermore, the supplier was coming under pressure internally from the finance team to reduce working capital in the form of safety stock. However, the supply chain leads were concerned about the message this would send about the resilience of their supply chains to customers.